Type2 Diabetes Mellitus Clinical Trial
Official title:
A Randomised Controlled Trial on a Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Glycaemic Control
Aim. To develop and compare a nurse-led smartphone-based self-management programme with an
existing nurse-led diabetes service on health-related outcomes of type 2 diabetes patients
with poor glycaemic control in Singapore.
Background. Over the past decades, Asia has emerged as the 'diabetes epicentre' in the world
due to rapid economic development, urbanisation, and nutrition transition. There is an
urgent need to develop more effective care management strategies in response to this rising
diabetes epidemic.
Design. A randomised controlled trial with pre- and repeated post-tests control group
design.
Methodology. A total of 128 type 2 diabetes patients with poor glycaemic control will be
recruited from the diabetes clinic of a public acute hospital in Singapore through
convenience sampling. Study participants will be randomly allocated either to the
experimental group or the control group. Outcome measures will include the 10-item General
Self-Efficacy Scale, 11-item Revised Summary of Diabetes Self-care Activities, and 19-item
Diabetes-Dependent Quality of Life. Data will be collected at three time points: baseline, 3
months, and 6 months from the baseline.
Discussion. It is expected that this programme will be an alternative offered to diabetes
patients to master their self-care management skills, in addition to the existing diabetes
service provided in diabetes clinics in Singapore hospitals. Furthermore, the
self-supporting and less resource-intensive nature of this programme, through the use of a
smartphone application as the mode of intervention delivery, will greatly reduce nurses'
direct contact time with patients and allow more time to be allocated to those who require
more attention.
Status | Not yet recruiting |
Enrollment | 128 |
Est. completion date | December 30, 2019 |
Est. primary completion date | June 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - have confirmed medical diagnosis of type 2 DM; - are 21 years old and above; - have blood test result of HbA1c > 8% in the most recent test indicating poor glycemic control; - possess and able to use smart mobile phone (e.g. Samsung Galaxy, iPhone) in their daily lives; and - are able to speak and read English or Chinese. Exclusion Criteria: - have suffered severe complications such as severe stroke, visual impairment, renal failure that interfere with self-care activities; - have known history of major psychiatric illness; - have reading and hearing difficulties. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National University, Singapore | National University Hospital, Singapore |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self-efficacy: change is being assessed | Self-efficacy will be assessed using the General Self-efficacy Scale (GSS), a 10-item questionnaire of the unidimensional measure of one's competence to deal with the challenging events encountered in various life situations | Change from baseline self-efficacy at 6 months | |
Secondary | Diabetes self-care activities: change is being assessed | Diabetes self-care activities will be measured using the 11-item Revised Summary of Diabetes Self-care Activities (RSDSCA) | Change from baseline diabetes self-care acitivities at 6 months | |
Secondary | Health-related Quality of Life: change is being assessed | Health-related Quality of Life will be measured using the 19-item Diabetes-Dependent Quality of Life (DDQoL) | Change from baseline health-related quality of life at 6 months | |
Secondary | Acute Diabetes Complications: change is being assessed | the number of frequency of acute diabetes complications including hypoglycaemia, DKA and HHS will be collected | Change from baseline acute diabetes complications at 6 months | |
Secondary | HbA1c: change is being assessed | HbA1c will be obtained from patient's medical record | Change from baseline HbA1c at 6 months | |
Secondary | Smoking status: change is being assessed | Smoking status will reported by the participant. | Change from baseline smoking status at 6 months | |
Secondary | Alcohol consumption: change is being assessed | Alcohol consumption will be reported by the participant | Change from baseline alcohol consumption at 6 months | |
Secondary | Diabetes-related hospital admission | number of diabetes-related hospital admission will be recorded | at the 6-month of the study period | |
Secondary | Visits to the emergency | number of diabetes-related emergency department visit will be recorded | at the 6-month of the study period | |
Secondary | Unplanned medical consultation | number of unplanned medical consultation due to diabetes problems will be recorded | at the 6-month of the study period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04082091 -
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
|
||
Active, not recruiting |
NCT02248311 -
"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
|
N/A | |
Completed |
NCT02653300 -
A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)
|
Phase 2 | |
Completed |
NCT03655535 -
Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes
|
Phase 2 | |
Completed |
NCT03256747 -
Effects of Neuromuscular Electrical Stimulation on Glucose Variability in Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05343767 -
Investigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus
|
N/A | |
Withdrawn |
NCT03675074 -
Neujia Anastomosis for Treatment of Obesity and Type II Diabetes
|
N/A | |
Withdrawn |
NCT03190798 -
Effects of Canagliflozin on Intravascular Volume and Hemodynamics
|
Phase 4 | |
Withdrawn |
NCT03437330 -
Empagliflozin Effect on Glucose Toxicity
|
Phase 4 | |
Withdrawn |
NCT03008395 -
Empowerment, Motivation and Medical Adherence (EMMA).
|
N/A | |
Not yet recruiting |
NCT05539066 -
AI Health Assistant and Type 2 Diabetes
|
N/A | |
Completed |
NCT03682445 -
Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus
|
N/A | |
Not yet recruiting |
NCT03239119 -
The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT03259789 -
Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
|
Phase 3 | |
Recruiting |
NCT03506230 -
Financial Incentives for Low Socioeconomic Diabetic Patients
|
N/A | |
Completed |
NCT03072407 -
MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM
|
Phase 1 | |
Completed |
NCT05668442 -
Feasibility of an Online Exercise Community Among Individuals With Type 2 Diabetes
|
||
Completed |
NCT02964572 -
Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes
|
N/A | |
Completed |
NCT02956044 -
Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
|
Phase 1 | |
Completed |
NCT02628392 -
A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
|
N/A |